Humana Sues Teva for Leading ‘Scheme’ to Inflate Generics Prices

Oct. 18, 2019, 6:35 PM UTC

Humana, the private health care insurer, sued Teva and more than a dozen other companies, accusing them in a sprawling antitrust lawsuit of conspiring to maintain “inflated and anti-competitive prices” that led to “egregious overcharges” on 124 generic drugs.

  • Humana is seeking damages in an amount to be proven at trial, according to 610-page complaint filed Friday in federal court in Philadelphia
  • Teva “spearheaded” the “scheme” but is part of “an even larger overarching conspiracy” in which defendants “routinely and systematically communicated with one another” to fix market shares, complaint says
  • Emails to Teva representatives weren’t immediately returned
  • Peak ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.